Status:

COMPLETED

Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Bipolar Disorder

Cocaine Dependence

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to determine if lamotrigine add-on therapy is associated with decreased cocaine craving and improvement in depressive symptom severity than placebo in a group of outpatien...

Detailed Description

One hundred and twenty (120) adult outpatients with bipolar I, II, not otherwise specified, or cyclothymic disorder and current cocaine dependence will be enrolled. After obtaining informed consent ba...

Eligibility Criteria

Inclusion

  • Diagnosis of bipolar I, II, not otherwise specified or cyclothymic disorders
  • Currently depressed or mixed mood state
  • Ages 18-70 years
  • Men or women
  • Self-reported cocaine use within 14 days prior to randomization
  • English or Spanish speaking
  • Baseline Hamilton Depression Rating Scale (HRSD17) score ≥ 10

Exclusion

  • Currently taking an enzyme inducing or inhibiting anticonvulsant (e.g. valproic acid, carbamazepine)
  • Current severe psychotic features (e.g. daily auditory hallucinations, fixed delusions, severely disorganized thought processes) that require antipsychotic therapy, and that do not appear to be secondary to cocaine use
  • Active suicidal ideation (plan and intent) or ≥2 attempts in past 12 months or any attempt in the past month
  • Highly unstable medical condition
  • Change in concomitant psychiatric medications (e.g. initiated antipsychotic) or in other substance abuse treatment (e.g. began intensive outpatient treatment) within 7 days prior to study entry
  • Vulnerable populations (e.g. pregnant or nursing women, prisoners, mentally retarded)

Key Trial Info

Start Date :

March 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

112 Patients enrolled

Trial Details

Trial ID

NCT00280293

Start Date

March 1 2006

End Date

January 1 2010

Last Update

September 26 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UT Southwestern Medical Center at Dallas

Dallas, Texas, United States, 75390-8849